Health news
Lessons learned from various presymptomatic neurodegenerative diseases may provide opportunities for early intervention, and perhaps even disease prevention of amyotrophic lateral sclerosis (ALS), according to a review published in the journal Brain. Studies have shown…
The Food and Drug Administration (FDA) has approved several revisions to the prescribing information for Zolgensma (onasemnogene abeparvovec-xioi). Zolgensma is an adeno-associated virus vector-based gene therapy indicated for the treatment of pediatric patients less than…
Among infants with type 1 spinal muscular atrophy (SMA), treatment with risdiplam was associated with improvements in motor function and meeting developmental motor milestones, according to study results published in The New England Journal of…
© 2005-2021 Top-Meds - All rights reserved. Our website services, content, and products are for informational purposes only. Top-Meds does not provide medical advice, diagnosis, or treatment. | Medical News 2021